Evaluation of Diabetic Medications Using Hybrid Fuzzy Pattern Classifier and TOPSIS


  • Soren Atmakuri Davidsen, M. Padmavathamma


Diabetes, Metformin, Anti-diabetic drug, Fuzzy Method


Given the plethora of pharmaceuticals available to regulate blood glucose levels, in medical decision-making, choose which ones to take for Type 2 Diabetes is a difficult task. Making decisions is made more difficult by the variety of hyperglycemia-lowering medications, each of which has distinct benefits and potential drawbacks. The study proposes a fuzzy Multi-Criteria Decision-Making model-based computer-aided healthcare decision-making system. This methodology combines the full multiplicative form of the TOPSIS method with Ratio Analysis and a modified version of Fuzzy Multi-Objective Optimization. The goal is to help with the decision-making process while choosing Type 2 Diabetes pharmaceutical therapy. The Fuzzy TOPSIS approach analyzes each option by taking into account all criteria in compliance with a published clinical guideline, On the other hand, while applying the TOPSIS technique to determine the relative relevance of particular criteria, expert opinions are taken into account. In order to address the drawbacks of conventional reference points and improve the ranking process in fuzzy multi-criteria decision-making, this study investigates an extended reference point technique inside the hybrid MCDM paradigm. The principal medicine, DPP-4-I, is confirmed by computational results, and Metformin is recognized as the second-line add-on therapy. The third, fourth, and fifth options are sulfonylurea, glucagon-like peptide1 receptor agonist, and insulin, in that order. To assess the effectiveness of the model, a sensitivity study is carried out by contrasting the outcomes with previous research, different fuzzy MCDM approaches, and an interval TOPSIS method based on observational data. Endocrinologists should be aware of the substantial agreement found between the final anti-diabetic drug rankings produced by the proposed hybrid model and alternative approaches.


Download data is not yet available.


Tella, Sri Harsha, and Marc S. Rendell. "DPP-4 inhibitors: focus on safety." Expert opinion on drug safety 14, no. 1 (2015): 127-140.

Eghbali-Zarch, Maryam, Reza Tavakkoli-Moghaddam, F. Esfahanian, Mohammad Mehdi Sepehri, and Amir Azaron. "Pharmacological therapy selection of type 2 diabetes based on the SWARA and modified MULTIMOORA methods under a fuzzy environment." Artificial intelligence in medicine 87 (2018): 20-33.

Mirghani, Hyder Osman. "An evaluation of adherence to anti-diabetic medications among type 2 diabetic patients in a Sudanese outpatient clinic." Pan African Medical Journal 34, no. 1 (2019).

Lekkas, Stavros, and Ludmil Mikhailov. "Evolving fuzzy medical diagnosis of Pima Indians diabetes and of dermatological diseases." Artificial Intelligence in Medicine 50, no. 2 (2010): 117-126.

Singh, Siddharth, Preet Paul Singh, Abha Goyal Singh, Mohammad Hassan Murad, and William Sanchez. "Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis." Official journal of the American College of Gastroenterology| ACG 108, no. 6 (2013): 881-891.

Mitri, Joanna, and Osama Hamdy. "Diabetes medications and body weight." Expert opinion on drug safety 8, no. 5 (2009): 573-584.

Krass, Ines, P. Schieback, and Teerapon Dhippayom. "Adherence to diabetes medication: a systematic review." Diabetic Medicine 32, no. 6 (2015): 725-737.

Sapkota, Sujata, Jo-anne Brien, Jerry Greenfield, and Parisa Aslani. "A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes—impact on adherence." PloS one 10, no. 2 (2015): e0118296.

White Jr, John R. "A brief history of the development of diabetes medications." Diabetes spectrum: a publication of the American Diabetes Association 27, no. 2 (2014): 82.

Plaz Torres, Maria Corina, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, and Edoardo G. Giannini. "Diabetes medications and risk of HCC." Hepatology 76, no. 6 (2022): 1880-1897.

Babiker, Amir, and Mohammed Al Dubayee. "Anti-diabetic medications: How to make a choice?." Sudanese journal of paediatrics 17, no. 2 (2017): 11.

Mann, Devin M., Diego Ponieman, Howard Leventhal, and Ethan A. Halm. "Predictors of adherence to diabetes medications: the role of disease and medication beliefs." Journal of behavioral medicine 32 (2009): 278-284.

Maruthur, Nisa M., Eva Tseng, Susan Hutfless, Lisa M. Wilson, Catalina Suarez-Cuervo, Zackary Berger, Yue Chu, Emmanuel Iyoha, Jodi B. Segal, and Shari Bolen. "Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis." Annals of internal medicine 164, no. 11 (2016): 740-751.

Lin, Jenny J., Emily J. Gallagher, Keith Sigel, Grace Mhango, Matthew D. Galsky, Cardinale B. Smith, Derek LeRoith, and Juan P. Wisnivesky. "Survival of patients with stage IV lung cancer with diabetes treated with metformin." American journal of respiratory and critical care medicine 191, no. 4 (2015): 448-454.

Chlebowski, Rowan T., Anne McTiernan, Jean Wactawski-Wende, JoAnn E. Manson, Aaron K. Aragaki, Thomas Rohan, Eli Ipp et al. "Diabetes, metformin, and breast cancer in postmenopausal women." Journal of clinical oncology 30, no. 23 (2012): 2844.

Hirst, J. A., A. J. Farmer, A. Dyar, T. W. C. Lung, and R. J. Stevens. "Estimating the effect of sulfonylurea on HbA 1c in diabetes: a systematic review and meta-analysis." Diabetologia 56 (2013): 973-984.

Zeller, Marianne, Nicolas Danchin, Dominique Simon, Alec Vahanian, Luc Lorgis, Yves Cottin, Jacques Berland et al. "Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction." The Journal of Clinical Endocrinology & Metabolism 95, no. 11 (2010): 4993-5002.

Simpson, Scot H., Sumit R. Majumdar, Ross T. Tsuyuki, Dean T. Eurich, and Jeffrey A. Johnson. "Dose–response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study." Cmaj 174, no. 2 (2006): 169-174.

Lawerence, David B., Kelly R. Ragucci, Laura B. Long, Beth S. Parris, and Lisa A. Helfer. "Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program." Journal of Managed Care Pharmacy 12, no. 6 (2006): 466-471.

Brunton, S. "GLP‐1 receptor agonists vs. DPP‐4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?." International journal of clinical practice 68, no. 5 (2014): 557-567.

Mathur, Vishal, Ozair Alam, Nadeem Siddiqui, Mukund Jha, Ajay Manaithiya, Sandhya Bawa, Naveen Sharma, Sultan Alshehri, Prawez Alam, and Faiyaz Shakeel. "Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents." Molecules 28, no. 15 (2023): 5860.

Tofé, Santiago, Iñaki Argüelles, Elena Mena, Guillermo Serra, Mercedes Codina, Juan Ramón Urgeles, Honorato García, and Vicente Pereg. "Real‐world GLP‐1 RA therapy in type 2 diabetes: A long‐term effectiveness observational study." Endocrinology, Diabetes & Metabolism 2, no. 1 (2019): e00051.

Jensterle, Mojca, Manfredi Rizzo, Martin Haluzík, and Andrej Janež. "Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review." Advances in Therapy 39, no. 6 (2022): 2452-2467.

Kalra, Sanjay, Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee et al. "Consensus recommendations on GLP-1 RA use in the management of type 2 diabetes mellitus: South Asian Task Force." Diabetes Therapy 10 (2019): 1645-1717.

Beeri, M. S., J. Schmeidler, J. M. Silverman, S. Gandy, M. Wysocki, C. M. Hannigan, D. P. Purohit, G. Lesser, H. T. Grossman, and V. Haroutunian. "Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology." Neurology 71, no. 10 (2008): 750-757.

Snyder, Richard W., and Jeffrey S. Berns. "Reviews: use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease." In Seminars in dialysis, vol. 17, no. 5, pp. 365-370. Oxford, UK: Blackwell Science Inc, 2004.

Mor, Deepali, and M. Ramachandran. "Optimization of solid wastes disposal strategy by Fuzzy TOPSIS method." Nature Environment and Pollution Technology 16, no. 1 (2017): 247.

Sun, Chia-Chi. "A performance evaluation model by integrating fuzzy AHP and fuzzy TOPSIS methods." Expert systems with applications 37, no. 12 (2010): 7745-7754.

Chu, T-C., and Y-C. Lin. "A fuzzy TOPSIS method for robot selection." The International Journal of Advanced Manufacturing Technology 21 (2003): 284-290.

Dymova, Ludmila, Pavel Sevastjanov, and Anna Tikhonenko. "An approach to generalization of fuzzy TOPSIS method." Information Sciences 238 (2013): 149-162.

Kalita, K., Madhu, S., Ramachandran, M. et al. Experimental investigation and parametric optimization of a milling process using multi-criteria decision making methods: a comparative analysis. Int J Interact Des Manuf (2022).

Sun, Chia-Chi, and Grace TR Lin. "Using fuzzy TOPSIS method for evaluating the competitive advantages of shopping websites." Expert systems with applications 36, no. 9 (2009): 11764-11771.

Galgali, Varsha S., M. Ramachandran, and G. A. Vaidya, Multi-Objective Optimal Placement and Sizing of DGs by Hybrid Fuzzy TOPSIS and Taguchi Desirability Function Analysis Approach, Electric Power Components and Systems, 1-12 (2021)

Chen, Ting-Yu, and Chueh-Yung Tsao. "The interval-valued fuzzy TOPSIS method and experimental analysis." Fuzzy sets and systems 159, no. 11 (2008): 1410-1428.

Wang, Ying-Ming, and Taha MS Elhag. "Fuzzy TOPSIS method based on alpha level sets with an application to bridge risk assessment." Expert systems with applications 31, no. 2 (2006): 309-319.

Ding, Ji-Feng. "An integrated fuzzy TOPSIS method for ranking alternatives and its application." Journal of Marine Science and Technology 19, no. 4 (2011): 2.

Junior, Francisco Rodrigues Lima, Lauro Osiro, and Luiz Cesar Ribeiro Carpinetti. "A comparison between Fuzzy AHP and Fuzzy TOPSIS methods to supplier selection." Applied soft computing 21 (2014): 194-209.

M. Ramachandran, U. Ragavendran, Vishal Fegade"Selection of Used Piston for Remanufacturing Using Fuzzy TOPSIS Optimization." Fuzzy Systems and Data Mining IV: Proceedings of FSDM 2018, vol 309 (2018): 61-67.




How to Cite

M. Padmavathamma, S. A. D. (2024). Evaluation of Diabetic Medications Using Hybrid Fuzzy Pattern Classifier and TOPSIS. International Journal of Intelligent Systems and Applications in Engineering, 12(21s), 1636–1645. Retrieved from https://ijisae.org/index.php/IJISAE/article/view/5639



Research Article